Viewpoint discusses the ethics of AI–generated compassion in cancer care and outlines 4 main points of concern. https://ja.ma/468Y2nH
JAMA Oncology
Book and Periodical Publishing
Chicago, Illinois 34,972 followers
A member of the JAMA Network, which includes JAMA, 11 specialty journals, and JAMA Network Open.
About us
JAMA Oncology is published online weekly, every Thursday, and in 12 print/online issues a year. The journal receives more than 6.4 million annual article views and downloads. Without any author fees, all research articles are made free access online 12 months after publication on the website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. The journal’s acceptance rate is 13%. The median time to first decision is 2 days, and 50 days with review. The Journal Impact Factor is 28.4, one of the highest ranking among oncology journals. All articles are published online first. Mary L. (Nora) Disis, MD, Director of the UW Institute of Translational Health Science and the Center for Translational Medicine in Women's Health, is the editor in chief.
- Website
-
https://jamanetwork.com/journals/jamaoncology
External link for JAMA Oncology
- Industry
- Book and Periodical Publishing
- Company size
- 5,001-10,000 employees
- Headquarters
- Chicago, Illinois
- Founded
- 2015
- Specialties
- Oncology
Updates
-
Chatbots can generate quality, empathetic, and readable responses to patient questions comparable to physician responses sourced from an online forum, suggests equivalence study. https://ja.ma/3LzbDuQ
-
This cross-sectional study assesses homologous recombination repair mutation genetic testing and associated characteristics among men with metastatic castration-resistant prostate cancer. https://ja.ma/3YrQs5Z
Genetic Testing in Men With mCRPC
jamanetwork.com
-
In this RCT, a multi-level intervention improved clinician-documented advance care planning, shared decision-making, palliative care and hospice use, and reduced hospitalizations more than a clinician-level intervention alone for patients with cancer. https://ja.ma/3YcGHrZ
Coaches Activating, Reaching, and Engaging Patients to Engage in Advance Care Planning
jamanetwork.com
-
Viewpoint presents an organizational and social template for medical communities to provide contemporary care for patients with cancer in rural and underserved states. https://ja.ma/4cJUVVz
Advancing Genomic Cancer Medicine in Rural and Underserved States
jamanetwork.com
-
In patients with node-positive breast cancer, axillary recurrence after omission of axillary lymph node dissection was rare with no difference by type of surgery (sentinel lymph node biopsy with dual-tracer mapping vs targeted axillary dissection). https://ja.ma/3W3uKlT
-
Most viewed in the last 7 days from JAMA Oncology: Is waterpipe tobacco smoking associated with an increased risk of cancer mortality in Vietnam? https://ja.ma/46e7g2c
-
In this case series of patients with Child-Pugh class B liver dysfunction, immunotherapy-based systemic therapy was associated with reduction in the risk of death compared with best supportive care. https://ja.ma/3LsTGy7
-
Most viewed in the last 7 days from JAMA Oncology: What is the association of selective pancreatic cancer surveillance with survival? https://ja.ma/3S0lkGz
-
Listen to an interview with Lee W. Jones author of "Neoadjuvant Exercise Therapy in Prostate Cancer: A Phase 1, Decentralized Nonrandomized Controlled Trial" with Vivek Subbiah. https://ja.ma/3S9d1bx
Neoadjuvant Exercise Therapy in Prostate Cancer
edhub.ama-assn.org